Table 1 Study patients, by group
GROUP 1 | GROUP 2 | GROUP 3 | GROUP 4 | Total | |||
|---|---|---|---|---|---|---|---|
Cohort 1 (RO6870810 0.30 mg/kg) sc + 1200 mg Atezolizumab i.v. | Cohort 2 (RO6870810 0.45 mg/kg) sc + 1200 mg Atezolizumab i.v. | Cohort 3 (RO6870810 0.65 mg/kg) sc + 1200 mg Atezolizumab i.v. | Cohort 1| (run-in with RO6870810 0.30 mg/kg) sc THEN (RO6870810 0.30 mg/kg) sc + 1200 mg Atezolizumab i.v. | Cohort 2| (run-in with RO6870810 0.45 mg/kg) sc THEN (RO6870810 0.45 mg/kg) sc + 1200 mg Atezolizumab i.v. | Expn Group TNBC | Expn Group OC | |
4 | 7 | 6 | 4 | 6 | 3 | 6 | 36 |